Anavex Life Sciences
AVXL
#7563
Rank
A$0.59 B
Marketcap
A$6.62
Share price
-1.12%
Change (1 day)
-43.78%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): A-$0.89

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is A-$0.86. In 2024 the company made an earnings per share (EPS) of A-$0.78 an increase over its 2023 EPS that were of A-$0.90.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.8913.22%
2024A-$0.78-13.33%
2023A-$0.90-3.23%
2022A-$0.9314.81%
2021A-$0.8120%
2020A-$0.68-16.67%
2019A-$0.8138.46%
2018A-$0.5918.18%
2017A-$0.50-21.43%
2016A-$0.63-35.38%
2015A-$0.98-36.27%
2014A-$1.54112.5%
2013A-$0.72-58.62%
2012A-$1.75-0%
2011A-$1.75-29.27%
2010A-$2.4751.85%
2009A-$1.63-0%
2008A-$1.63237.5%
2007A-$0.48
2006N/A-100%
2005A-$0.06022499.97%
2004A-$0.01004

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
A$3.60-519.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A-$0.07527-91.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
A$1.51-275.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
A-$91.84 10,601.75%๐Ÿ‡บ๐Ÿ‡ธ USA